ASH 2018 | Opioid use in sickle cell is not associated with in-hospital mortality in the US

Oladimeji Akinola Akinboro

Oladimeji Akinola Akinboro, MBBS, of Boston University School of Medicine and Boston Medical Center, Boston, MA, presents the finding from a national inpatient sample of sickle cell disease (SCD) in the US, which revealed that opioid use in SCD patients is not associated with in-hospital mortality. This indicates that use for pain management appears safe and should not be witheld when indicated.

Share this video